Literature DB >> 7759779

Involvement of mu-opioid receptors in the modulation of pituitary-adrenal axis in normal and stressed rats.

E C degli Uberti1, F Petraglia, M Bondanelli, A L Guo, A Valentini, S Salvadori, M Criscuolo, R E Nappi, A R Genazzani.   

Abstract

The availability of the most selective, high-affinity, natural opioid agonists for mu-receptors (dermorphin-DM) and delta-receptors (deltorphin-DT) has provided the possibility for in vivo studying of the role of acute and chronic activation of mu- and delta-opioid receptors on the functional activity of the hypothalamus-pituitary-adrenocortical (HPA) axis, both in basal conditions and in response to an acute stress in adult male rats. Plasma corticosterone (CS) and beta-endorphin-like-immunoreactivity (beta-EP-LI) levels were measured by specific radioimmunoassays before and after 5 and 30 minutes from the exposure to cold (3 +/- 0.5 C) water and forcing them to swim for 10 minutes (acute cold swimming stress). Acute administration of DM, the specific mu-receptor agonist, enhanced basal and stress induced plasma levels of CS and beta-EP-LI. These effects were antagonized by pretreatment with naloxone, specific mu-opioid receptor antagonist, but not by naltrindole, a delta-opioid receptor antagonist. Long-term administration of DM did not alter resting plasma levels of CS and beta-EP-LI, but significantly reduced stress-induced increase of these hormones. Both the acute and chronic administration of the DT, highly selective delta-opioid receptors agonist, failed to modify resting and stress induced hormone levels. Our present data show that DM throughout mu-opioid receptors, but not DT, modulates the response of HPA axis to acute stress in rats, increasing or decreasing the release of CS and beta-EP-LI when acutely or chronically administered, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759779     DOI: 10.1007/BF03349688

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  37 in total

1.  The role of the hypothalamus in pituitary-adrenal activation and antidiuresis by morphine.

Authors:  R GEORGE; E L WAY
Journal:  J Pharmacol Exp Ther       Date:  1959-02       Impact factor: 4.030

Review 2.  Selective opioid receptor agonists and antagonists: research tools and potential therapeutic agents.

Authors:  D M Zimmerman; J D Leander
Journal:  J Med Chem       Date:  1990-03       Impact factor: 7.446

3.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

4.  Synthesis and pharmacological activity of dermorphin and its N-terminal sequences.

Authors:  S Salvadori; G Sarto; R Tomatis
Journal:  Int J Pept Protein Res       Date:  1982-05

5.  Opioid inhibition of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation of rats.

Authors:  P M Plotsky
Journal:  Regul Pept       Date:  1986-12-30

6.  Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats.

Authors:  S Suemaru; K Hashimoto; Z Ota
Journal:  Acta Med Okayama       Date:  1985-12       Impact factor: 0.892

7.  Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat.

Authors:  J C Buckingham
Journal:  Eur J Pharmacol       Date:  1984-02-17       Impact factor: 4.432

8.  Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.

Authors:  J C Buckingham; T A Cooper
Journal:  Neuroendocrinology       Date:  1984-05       Impact factor: 4.914

9.  Pharmacological data on dermorphins, a new class of potent opioid peptides from amphibian skin.

Authors:  M Broccardo; V Erspamer; G Falconieri Erspamer; G Improta; G Linari; P Melchiorri; P C Montecucchi
Journal:  Br J Pharmacol       Date:  1981-07       Impact factor: 8.739

10.  Effects of opioid peptides on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.

Authors:  F Yajima; T Suda; N Tomori; T Sumitomo; Y Nakagami; T Ushiyama; H Demura; K Shizume
Journal:  Life Sci       Date:  1986-07-14       Impact factor: 5.037

View more
  12 in total

Review 1.  Social consequences of ethanol: Impact of age, stress, and prior history of ethanol exposure.

Authors:  Elena I Varlinskaya; Linda P Spear
Journal:  Physiol Behav       Date:  2014-11-26

2.  Effect of mu-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats.

Authors:  J S Walker; A K Chandler; J L Wilson; W Binder; R O Day
Journal:  Inflamm Res       Date:  1996-11       Impact factor: 4.575

3.  Effects of acute pain medications on posttraumatic stress symptoms in early aftermath of trauma.

Authors:  Aaron S Grau; Hong Xie; Roberta E Redfern; Mohamad Moussa; Xin Wang; Chia-Hao Shih
Journal:  Int Clin Psychopharmacol       Date:  2022-05-02       Impact factor: 2.023

4.  Mu-opioid and corticotropin-releasing-factor receptors show largely postsynaptic co-expression, and separate presynaptic distributions, in the mouse central amygdala and bed nucleus of the stria terminalis.

Authors:  A Jaferi; V M Pickel
Journal:  Neuroscience       Date:  2009-01-08       Impact factor: 3.590

5.  Benefits of Distinguishing between Physical and Social-Verbal Aspects of Behavior: An Example of Generalized Anxiety.

Authors:  Irina Trofimova; William Sulis
Journal:  Front Psychol       Date:  2016-03-14

6.  A Study of the Coupling of FET Temperament Traits with Major Depression.

Authors:  Irina N Trofimova; William Sulis
Journal:  Front Psychol       Date:  2016-11-25

7.  Effects of buprenorphine in the adrenal, thyroid, and cytokine intra-operative responses in a rat model (Rattus norvegicus): a preliminary study.

Authors:  Nuno M Félix; Rodolfo O Leal; I Goy-Thollot; Ronald S Walton; Solange A Gil; Luísa M Mateus; Ana S Matos; Maria M R E Niza
Journal:  Iran J Basic Med Sci       Date:  2017-04       Impact factor: 2.699

8.  Molecular characterization of the stress network in individuals at risk for schizophrenia.

Authors:  Mandy Meijer; Arlin Keo; Judith M C van Leeuwen; Oleh Dzyubachyk; Onno C Meijer; Christiaan H Vinkers; Ahmed Mahfouz
Journal:  Neurobiol Stress       Date:  2021-02-10

9.  Delta-Opioid Receptors Play a Role in the Control of Selected Parameters Related to Stress and Brain Plasticity Under Non-stress and/or Stress Conditions.

Authors:  P Chomanic; L Karailievova; J Graban; D Jezova
Journal:  Cell Mol Neurobiol       Date:  2021-03-08       Impact factor: 5.046

Review 10.  Functionality versus dimensionality in psychological taxonomies, and a puzzle of emotional valence.

Authors:  Irina Trofimova
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-04-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.